AI has learned the ins and outs of proteins. Gene editing gives scientists control of life’s molecular machinery. Together they could lead to a revolution in biotechnology.
Academic rigor, journalistic flair
Articles on Gene editing
Displaying 1 - 20 of 103 articles
Champions of xenotransplantation see it as the solution to organ shortages across the world. But this technology has other applications.
Biotech firms are using climate goals opportunistically in an attempt to force through the deregulation of genetically modified crops.
Science is getting closer to finding a cure for HIV.
The three flu pandemics of the 20th century originated from birds, making it critical to fight bird flu. Breakthroughs in gene-editing chickens show promise for eliminating the disease in the future.
Scientists can create viable eggs from two male mice. In the wake of CRISPR controversies and restrictive abortion laws, two experts start a dialogue on ethical research in reproductive biology.
Chemist David Liu explains how gene editing is paving the way to treating and even curing certain genetic diseases.
Gene editing promises everything from treatments for serious conditions like sickle cell disease to the resurrection of the dodo.
Scientific and public uproar resulted when the Chinese scientist announced the births of the first human babies with heritable edits to their genes. A new documentary reexamines the saga.
The biotech sector uses climate change as an urgent argument for more funding and fewer regulatory hurdles. But the urgency of climate change raises the risk of superficial claims and actions.
As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.
The rapid rate of species declines means we should trial potential solutions before it’s too late.
Rabies, for example, is a naturally occurring ‘zombie’ disease.
Hox genes make sure all your body parts grow in the right place. Understanding how they work can reveal the process of evolution and lead to potential treatments for congenital birth defects.
Field trials of genetically edited crop plants are to be allowed in England under new government proposals.
Catherine Price, sociologist, and Nicola Patron, synthetic plant biologist, discuss the promises, dangers and concerns around gene edited and GM crops.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
The achievement didn’t live up to the hype, but it has illuminated new areas of ‘genetic dark matter’.
Using ‘base editing’, researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don’t live past the age of 13.
Top contributors
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Associate professor, Queensland University of Technology
-
Professor of Chemistry, Connecticut College
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Shah Rising Star Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Doctoral Student in Biochemistry, University of Washington
-
Director of Research and Professor of Pathology, Dalhousie University
-
Professor of Advanced Technology Transitions, Arizona State University
-
Research fellow, The University of Queensland
-
Senior Lecturer, School of BioSciences, The University of Melbourne
